Chaofeng Long
Impact in
-
- Traditional Chinese Medicine Analysis
- Pharmacology top 10%
Papers in
-
- Bioactive natural compounds 4
- Natural product bioactivities and synthesis 3
- Ginseng Biological Effects and Applications 3
-
- Phytochemistry and Biological Activities 4
- Co-authors
- Minghai Tang (6 shared papers)Peibo Li (5 shared papers)Weiwei Su (4 shared papers)Zhuowei Liu (6 shared papers)Zhiyong Qian (4 shared papers)Lijuan Chen (4 shared papers)Xiaoxin Chen (4 shared papers)Hong Liu (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Biomedical Nanotechnology (2 papers)Journal of Medicinal Chemistry (1 paper)Acta Pharmaceutica Sinica B (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chaofeng Long
23 papers receiving 492 citations
Peers
Comparison fields: 5 of 82
- Complementary and alternative medicine 51
- Pharmacology 44
- Biomaterials 68
- Molecular Biology 275
- Toxicology 11
Countries citing papers authored by Chaofeng Long
This map shows the geographic impact of Chaofeng Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofeng Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofeng Long more than expected).
Fields of papers citing papers by Chaofeng Long
This network shows the impact of papers produced by Chaofeng Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofeng Long. The network helps show where Chaofeng Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaofeng Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 93 | |
| 2 | 2014 | 72 | |
| 3 | 2016 | 37 | |
| 4 | 2014 | 31 | |
| 5 | 2016 | 29 | |
| 6 | 2014 | 27 | |
| 7 | 2019 | 25 | |
| 8 | 2014 | 22 | |
| 9 | 2013 | 22 | |
| 10 | 2020 | 20 | |
| 11 | 2017 | 18 | |
| 12 | 2013 | 18 | |
| 13 | 2014 | 17 | |
| 14 | 2014 | 11 | |
| 15 | 2013 | 9 | |
| 16 | 2018 | 9 | |
| 17 | 2014 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2014 | 6 |
About Chaofeng Long
Chaofeng Long is a scholar working on Molecular Biology, Plant Science, Oncology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 497 indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (4 papers), Bioactive natural compounds (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Traditional Chinese Medicine Analysis (3 papers), Natural product bioactivities and synthesis (3 papers), Ginseng Biological Effects and Applications (3 papers), Lipid metabolism and disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Complementary and alternative medicine (51 citations), Pharmacology (44 citations), Biomaterials (68 citations), Molecular Biology (275 citations) and Toxicology (11 citations). Chaofeng Long has collaborated with scholars based in China and United States. Frequent co-authors include Minghai Tang, Peibo Li, Weiwei Su, Zhuowei Liu, Zhiyong Qian, Lijuan Chen, Xiaoxin Chen, Hong Liu, Xiaoxin Chen and Aihua Peng. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biomedical Nanotechnology, Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.